@gametogen

Our Website

LinkedIn

Twitter

Instagram

Human-induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation

Donor side effects experienced under minimal controlled ovarian stimulation (COS) with in vitro maturation (IVM) versus conventional COS for in vitro fertilization (IVF) treatment

Ovarian support cell in vitro maturation (OSC-IVM) results in healthy murine live births with no evidence of reprotoxicology in a multigenerational study

Directed differentiation of human iPSCs to functional ovarian granulosa-like cells via transcription factor overexpression

Human induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation

PR Newswire: Gameto Announces Path Towards a U.S. Phase 3 Trial and Executive and Advisor Appointments

PR Newswire: Gameto Announces Patient Experience Data Demonstrating Investigational In Vitro Maturation Solution Well Tolerated with Higher Patient Satisfaction Rates than Conventional Fertility Stimulation

The Boston Globe: The next frontier in baby-making

FemTech Insider: Gameto’s IVM Candidate Fertilo

PR Newswire: Gameto at ASRM 2023

PR Newswire: Gameto CEO Recognized Among the Most Exceptional Entrepreneurs by Goldman Sachs

MIT Tech Review: This biotech CEO decided to take her own (fertility) medicine

The Economist: The most personal technology

WSJ: What if We Could Get Rid of Menopause?

Fierce Healthcare: Menopause is a largely untapped market

PR Newswire: Gameto Named as 2023 Technology Pioneer by WEF

Stat News: Rethinking IVF

The New Yorker: The Future of Fertility